Legacy Education Inc. (LGCY) - Q1 2026 10-Q Summary
Business Context and Reporting Period
Company: Legacy Education Inc. (dba High Desert Medical College, Central Coast College, Integrity College of Health, and Contra Costa Medical Career College).
Reporting Period: Three months ended September 30, 2025 (Fiscal Q1 2026).
Business Model: Career-focused, post-secondary education provider operating multiple campuses in California. Programs include healthcare, veterinary, medical IT, and business management.
Regulatory Status: Accredited by ACCET and ABHES; approved by the Bureau for Private Postsecondary Education (BPPE). The company is an "emerging growth company" and a "smaller reporting company."
Key Financial Metrics
| Metric | Q1 2026 (Sep 30, 2025) | Q1 2025 (Sep 30, 2024) |
|---|---|---|
| Total Revenue | $19,401,023 | $14,005,091 |
| Net Income | $2,186,960 | $2,090,753 |
| Operating Income | $2,698,650 | $2,672,276 |
| Net Cash from Operating Activities | $1,056,335 | $3,185,254 |
| Cash and Cash Equivalents | $20,586,087 | $21,492,618 |
| Total Debt (Current + Long-term) | $776,856 | $N/A (See Note 10) |
| Operating Margin | 13.9% | 19.1% |
| Net Margin | 11.3% | 14.9% |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 38.5% ($5.4M) driven primarily by increased enrollment across campuses.
- Expense Expansion: Total costs and expenses rose 47.4% ($5.4M). Educational services increased 43.3% due to staffing and rent; General and Administrative (G&A) expenses increased 54.0% due to marketing, professional fees, and bad debt.
- Margin Compression: Despite revenue growth, operating margin declined from 19.1% to 13.9% as expenses outpaced revenue growth.
- Cash Flow Decline: Net cash provided by operating activities decreased significantly ($2.1M drop) due to a $2.8M increase in accounts receivable and higher prepaid expenses, partially offset by an increase in income taxes payable.
- Acquisition Impact: The company acquired Contra Costa Medical Career College (CCMCC) in December 2024. Pro forma data suggests the acquisition contributed to the revenue base.
Guidance, Outlook, Risks, and Unusual Items
- Regulatory Risks: The company faces significant uncertainty regarding U.S. Department of Education (ED) regulations, including the "One Big Beautiful Bill Act" (OBBBA), negotiated rulemaking on loan limits (RISE Committee), and accountability measures (AHEAD Committee). Final regulations are expected to take effect July 1, 2026.
- Government Shutdown: A federal government shutdown occurred in October 2025, ending November 12, 2025. While ED continued disbursements, future shutdowns pose a risk to funding flows.
- 90/10 Revenue Test: The company must maintain at least 10% of revenue from non-federal sources. For FY 2024, subsidiaries ranged from 79.51% to 87.55% federal reliance. FY 2025 calculations are due December 31, 2025.
- Financial Responsibility: The composite score for FY 2024 was 3.0 (threshold is 1.5). The FY 2025 score is pending.
- Unusual Items: No material litigation or impairments were reported. Share-based compensation expense increased to $269,246 from $67,031 year-over-year.
Investor Verification Checklist
- Enrollment Quality: Verify if the 38.5% revenue growth is sustainable or driven by one-time enrollment spikes, given the 54% increase in G&A expenses.
- Accounts Receivable Aging: Investigate the $2.8M increase in accounts receivable and the adequacy of the allowance for doubtful accounts ($1.86M) given the reliance on Title IV funds.
- Regulatory Compliance: Monitor the upcoming December 31, 2025, filing for the 90/10 revenue test and the composite score for FY 2025 to ensure continued Title IV eligibility.
- Debt Servicing: Review the maturity schedule for the $776k in debt and the $15.5M in operating lease liabilities to assess liquidity pressure.
- Marketing Efficiency: Assess the return on investment for the $1.6M marketing spend in Q1 2026 compared to the prior year's $1.2M.